Biosimilars or semi-similars?
Nat Biotechnol
.
2015 Jan;33(1):19-20.
doi: 10.1038/nbt.3083.
Authors
Huub Schellekens
1
,
Ellen Moors
1
Affiliation
1
Department of Innovation, Utrecht University, Utrecht, the Netherlands, and Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
PMID:
25574627
DOI:
10.1038/nbt.3083
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Drug Approval / legislation & jurisprudence
Substances
Antibodies, Monoclonal